Although the M 2 muscarinic acetylcholine receptor (mAChR) is the predominant functional mAChR subtype in the heart, some responses of the cardiovascular system to acetylcholine (ACh) may be mediated by other mAChR subtypes. The potential effect of M 1 mAChR on heart function was investigated using M 1 knockout (M 1 -KO) mice. In vivo cardiodynamic analysis showed that basal values of heart rate (HR), developed left ventricular pressure (DLVP), left ventricular dP/dt max (LV dP/ dt max ), and mean blood pressure (MBP) were similar between wild-type (WT) and M 1 -KO mice. Injection of the putative M 1 -selective agonist 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium (McN-A-343) produced an increase in LV dP/dt max , DLVP, HR, and MBP in WT mice but did not affect hemodynamic function in the M 1 -KO mice. The stimulatory effect of McN-A-343 in WT mice was blocked by pretreatment with propranolol, indicating that stimulation of the M 1 mAChRs on sympathetic postganglionic neurons evoked release of catecholamines. Intravenous injection of ACh in both WT and M 1 -KO mice caused atrioventricular conduction block, without a significant change in the frequency of atrial depolarization, or atrial fibrillation. Immunoprecipitation and reverse transcriptase-polymerase chain reaction failed to detect the expression of M 1 mAChR in cardiac tissue from WT mice. The carbacholinduced increase of phospholipase C activity in cardiac tissues was not different between WT and M 1 -KO mice. These results demonstrate that 1) activation of M 1 mAChR subtype on sympathetic postganglionic cells results in catecholamine-mediated cardiac stimulation, 2) M 1 mAChR is not expressed in mouse heart, and 3) administration of ACh to mice induces arrhythmia.
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Stimulation of the parasympathetic postganglionic neurons causes the release of acetylcholine (ACh) that acts on muscarinic ACh receptors (mAChRs) on the myocardial cell membrane. There are five mammalian mAChR subtypes that preferentially couple to either the inhibition of adenylyl cyclase activity (M 2 and M 4 subtypes) or to the stimulation of phospholipase C (PLC) activity (M 1 , M 3 , and M 5 subtypes) (Bonner, 1989) . The M 2 mAChR is the predominant muscarinic receptor subtype in mammalian heart (Brann et al., 1993; Caulfield, 1993) . Activation of these M 2 mAChRs inhibits the activity of adenylyl cyclase, closes calcium channels, lowers the hyperpolarization-activated pacemaker current, and activates an inwardly rectifying potassium channel. These changes cause both negative chronotropic and inotropic effects on the heart (Caulfield, 1993) .
Accumulating evidence indicates that other mAChR subtypes also contribute to the regulation of heart rate and contractility. The novel muscarinic agonist McN-A-343 has pressor activity in mammals (Roszkowski, 1961) . When injected in dogs and cats, McN-A-343 raised blood pressure, an effect blocked by pretreatment with the muscarinic antagonist atropine. The McN-A-343-mediated hypertension in vivo was also antagonized by adrenergic blockade, suggesting that McN-A-343 is a muscarinic agonist that acts as a sympathomimetic agent. Pretreatment of dogs with reserpine blocks the pressor effect of McN-A-343. In awake rats, McN-A-343 induced hypertension and tachycardia, which are antagonized by propranolol (Martin, 1996) . Adrenal demedullation had no effect on the tachycardia, whereas treatment with guanethidine suppressed both tachycardia and hypertension (Martin, 1996) . Taken together, these results demonstrate that the muscarinic agonist McN-A-343 evokes both tachycardia and hypertension by releasing catecholamines from the sympathetic nerve endings, with only a minor role for the adrenal glands.
The muscarinic subtype that mediates the cardiostimulatory effect of McN-A-343 has not been clearly identified. The increase in blood pressure and heart rate after McN-A-343 injection in adult rats was blocked by low concentrations of the M 1 /M 4 muscarinic antagonist pirenzepine (Hammer and Giachetti, 1982; Wilffert et al., 1983) , suggesting that either the M 1 or M 4 subtype mediated the cardiostimulatory effects of McN-A-343. In addition, functional studies with cloned mAChR indicate that McN-A-343 can activate multiple muscarinic receptor subtypes with greatest efficacy at the M 4 receptor (Caulfield and Birdsall, 1998) . Furthermore, the M 1 , M 2 , and M 4 mAChR subtypes are all expressed in sympathetic ganglia (Caulfield, 1993) .
Pharmacological studies have also shown that muscarinic agonists can elicit a stimulatory effect on the mammalian heart. ACh caused a positive inotropic effect in human heart (Du et al., 1995) and in sheep and in canine cardiac Purkinje fibers (Gilmour and Zipes, 1985; Iacono and Vassalle, 1989) . In isolated mouse atria ACh induces a biphasic effect on both maximum upstroke velocity of the action potential and inotropic response (Islam et al., 1998; Nishimaru et al., 2000) , whereas in isolated perfused rat heart, ACh caused a dosedependent increase in perfusion pressure (Hoover and Neely, 1997) . It has been suggested that the positive inotropic action of ACh is a protective mechanism to prevent excessive inhibition of cardiac function at high concentrations of ACh (Pappano, 1991) . However, the physiological effects of mAChRmediated stimulation of the heart, particularly in vivo, are not well characterized and their mechanisms of action are poorly understood.
Other studies have demonstrated that other mAChR subtypes besides M 2 may be involved in cardiac function. For example, in canine atrial myocytes a novel K ϩ current is regulated by an M 3 mAChR subtype (Shi et al., 1999a,b) . The ACh-mediated increase in rate of contraction in neonatal ventricular myocytes was insensitive to the M 2 antagonist AFDX-116 but antagonized by the M 1 /M 4 antagonist pirenzepine (Gallo et al., 1993) . In guinea pig cardiomyocytes carbachol mediated a pirenzepine-sensitive increase in the Ltype Ca 2ϩ channel activity (Gallo et al., 1993) . These studies suggest that the M 1 or M 4 mAChR may be involved in the regulation of the heart. More recently, RT-PCR analysis has shown the expression of the M 1 mAChR subtype in rat and guinea pig ventricular cells (Gallo et al., 1993; Sharma et al., 1996) and the M 3 and M 4 mAChR subtypes in dog atrial cells (Shi et al., 1999b) .
Although there is data indicating that the M 1 receptor may regulate cardiovascular function by acting either in the heart and/or the sympathetic ganglia, there appear to be considerable differences due either to species differences or lack of adequate selectivity of pharmacological agents. We took advantage of the M 1 -KO mice previously generated in our laboratory (Hamilton et al., 1997) to determine the role of the M 1 mAChR in the regulation of cardiovascular function in mouse.
Materials and Methods
In Vivo Cardiodynamics. All procedures were approved by the University of Washington Institutional Animal Care and Use Committee. Mice (ϳ6 months old) were anesthetized by intraperitoneal injection of tribromoethanol (Avertin, 0.4 mg/kg; Aldrich, Milwaukee, WI) and urethane-␣-chloralose (750 mg/kg; 50 mg/kg). Mice were ventilated with a volume displacement ventilator (Harvard 687; Harvard Apparatus, Holliston, MA) and end respiratory CO 2 was recorded (96282-ND-PR; Columbus Instruments, Columbus, OH) and maintained between 2.8 and 3.2%. Body temperature was maintained at 37°C by using a rectal probe and proportional temperature controller (Harvard 7129; Harvard Apparatus) with a heating blanket. Where indicated, mice were bilaterally vagotomized to avoid vagal reflexes. The jugular vein was catheterized for drug injections (25 l each).
A catheter tip pressure transducer (1.4F; Millar; Houston, TX) was inserted into the right carotid artery and advanced into the aorta (for determination of the aortic pressure) or the left ventricle (for the determination of developed left ventricular pressure). The left ventricular dP/dt max was calculated online from the left ventricular pressure. The heart rate was calculated from the left ventricular pressure. The mean blood pressure (MBP) was calculated online from the aortic pressure. Each data point represents an average of five sequential measurements. Left ventricular dP/dt max (LV dP/ dt max ) is expressed in millimeters of mercury per second, developed left ventricular pressure (DLVP) and MBP are expressed in millimeters of mercury, and the heart rate is expressed in beats per minute (bpm). In some experiments, ECGs were recorded from electrodes placed under the skin. In these experiments the atrial rate was calculated from the P-P intervals.
RNA Extraction from Adult Heart. Total RNA from cortex, cerebellum, and whole heart from adult mice was extracted with TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol with modification (Chomczynski and Sacchi, 1987) .
RT-PCR. RT was performed at 42°C for 60 min by using 200 U of Moloney murine leukemia virus reverse transcriptase (Promega, Madison, WI) in a volume of 50 l. The amplification reaction was carried out in the same tube in a final volume of 100 l with 1.25 U of a thermostable Taq DNA polymerase (M186A; Promega). The temperature steps were 1 min at 94°C, 1 min at 56°C, and 1 min at 73°C. Forty-five cycles were performed and one additional cycle was added with a final elongation time of 10 min at 73°C. Each cardiac preparation was tested for DNA contamination in a parallel reaction performed in the absence of reverse transcriptase. The primers used for PCR were the 5Ј-primer 5Ј-ggatccggatccaaaggtggtggc-3Ј and the 3Ј-primer 5Ј-gaattcgaattctttcttggtgggcctcttgacgtg-3Ј. The reverse transcription was performed with the same 3Ј-primer.
Southern Blot. The RT-PCR products were separated on a 1.0% agarose gel by electrophoresis and transferred to a nylon membrane. A 32 P-labeled 1.8-kilobase KpnI-BamHI genomic fragment (10 8 cpm/ mg) containing the entire coding M 1 receptor region (Shapiro et al., 1988) was used as a probe.
[ 3 H]QNB Binding Assay and Immunoprecipitation. Membrane isolation and solubilization, [
3 H]QNB binding assays, and immunoprecipitation with specific anti-M 1 and anti-M 2 antibodies were performed as described in Hamilton et al. (1997) .
Phosphatidylinositol Hydrolysis Assay. WT and M 1 -KO adult mice (ϳ6 months old) were sacrificed by CO 2 intoxication. Hearts were quickly transferred to prewarmed Krebs' buffer containing 118 mM NaCl, 4.7 mM KCl, 3 mM CaCl 2 , 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 0.5 mM EDTA, 25 mM NaHCO 3 , and 10 mM glucose, pH 7.4 at 37°C. Atria and ventricles were cut into small pieces (1-3 mm) and incubated in 0.5 ml of oxygenated (95% O 2 , 5% CO 2 ) Krebs' buffer containing 4 Ci/ml of [ 3 H]myo-inositol (specific activity 16 Ci/mmol; Amersham Biosciences, Piscataway, NJ) for 90 min at 37°C with gentle agitation. Tissues were then washed with phosphate saline solution-LiCl solution (118 mM NaCl, 4.7 mM KCl, 3 mM CaCl 2 , 1.2 mM KH 2 PO 4 , 10 mM glucose, 0.5 mM EDTA, 20 mM HEPES, and 50 mM LiCl) and incubated again for 30 min in this solution at 37°C. Carbachol (0.001-1 mM final concentration) was then added and the samples were incubated for an additional 30 min at 37°C.
The tissues were homogenized by hand with a glass-glass homogenizer and the [ 3 H]inositol phosphates and total labeled inositol phospholipids were extracted (Scherer and Nathanson, 1990; Mende et al., 1998) . Samples of ventricular tissues were assayed in duplicate, whereas the amount of atrial tissue only allowed a single determination per sample of unstimulated and 1 mM carbachol-stimulated values. The normalized values (ratio of inositol phosphates to total inositol phospholipids) are expressed as percentage of stimulation over the control value.
Statistics. Data are expressed as mean Ϯ S.E.M. Two-tailed unpaired t tests with 95% confidence limits or ANOVA was performed as indicated in the figure legends. The results were considered statistically significant if p Ͻ 0.05.
Results

M 1 mAChR Have a Catecholamine-Dependent Stimulatory Effect on Heart in Vivo
Basal Function. Cardiodynamic analyses were carried out to determine whether the lack of M 1 mAChRs affected basal cardiac function. The basal functions of the heart (LV dP/dt max , DLVP, HR) were recorded in vagotomized mice before administration of drugs (Table 1) . There is no statistical difference in these variables between the WT and M 1 -KO mice, indicating that the lack of M 1 mAChRs did not alter basal cardiac function.
Vagotomy. To ensure that there were no differences in basal cardiac function between WT and mutant mice that were obscured by vagotomy, the change of heart rate due to vagotomy was also determined. These recordings were performed in separate groups of mice without cardiac catheterization. The heart rate was determined from ECG before and after bilateral vagotomy. Although a moderate tachycardia was observed as expected in both groups after vagotomy, the change was not statistically different between the WT (ϩ69 Ϯ 19 bpm; n ϭ 4) and M 1 -KO mice (ϩ50 Ϯ 11 bpm; n ϭ 5).
The mean blood pressure was also determined in mice after catheterization before and after bilateral vagotomy. Vagotomy induces a moderate increase in MBP in both groups (ϩ7.5 Ϯ 5.5 mm Hg in WT; ϩ8.2 Ϯ 3.3 mm Hg in M 1 -KO mice). There is no statistical difference between WT and M 1 -KO mice.
McN-A-343 Induces Stimulatory Effects on Mouse Heart Mediated by ␤-Adrenergic Receptors. Administration of the muscarinic agonist McN-A-343 (350 g/kg) into bilateral vagotomized WT mice increased DLVP, LV dP/dt max , and heart rate ( Fig. 1, A-C) . This effect was totally inhibited by pretreatment with the ␤-adrenergic receptor antagonist propranolol (1 mg/kg).
Stimulatory Effect of McN-A-343 on Heart Is Mediated by M 1 mAChR. We took advantage of the M 1 -KO mice McN-A-343 was also injected in a separate group of WT and M 1 -KO mice to record the mean blood pressure (Fig. 4) . To ensure that vagotomy did not alter the responses due to drug administration, the effects of McN-A-343 administration were determined both before and after vagotomy. In the WT mice, McN-A-343 induced tachycardia and increased blood pressure before vagotomy ( (Fig. 4, A and C) . The M 1 -KO mice did not respond to injection of McN-A-343 (Fig. 4, B and D) .
Nicotinic Responses Are Similar in Wild-Type and Knockout Mice. The agonist nicotine was injected at the end of each experiment as a positive internal control to test the effects of stimulation of nicotinic receptors in the sympathetic ganglia. As expected, nicotine induced a positive inotropic effect as well as tachycardia in both WT and M 1 -KO mice (Fig. 5) . The responses were not statistically different between the two groups. The effects of nicotine in M 1 -KO mice demonstrate that the absence of a response to McN-A-343 was not due to an artifactual disruption of sympathetic effects on the heart. ACh-Induced Responses Are Similar in WT and M 1 -KO Mice. To determine whether the lack of M 1 mAChR expression induced any change in M 2 mAChR responsiveness, ACh was injected in WT and M 1 -KO mice. Endogenously released ACh acts on M 2 mAChR in the heart to induce both negative chronotropic and inotropic responses (Fleming et al., 1992; Caulfield, 1993) . We therefore expected that administration of ACh would result in sinoatrial node bradycardia, which could be recorded on an ECG trace as a longer P-P wave interval and a moderate decrease in maximum LV dP/dt max (the negative inotropic effect).
Surprisingly, the atrial rate was not modified after ACh administration (see the P-wave intervals before and after ACh administration; Fig. 6 ). The main observed effects after administration of ACh, in mice, were 1) dropped QRS complexes, which is typical of atrioventricular conduction block; and 2) atrial flutter or atrial fibrillation alone or with atrioventricular block. The resultant change in DLVP is probably due to the change in ventricular rate rather than a direct inotropic effect. These effects were observed in bilaterally vagotomized propranolol-pretreated mice; similar effects were also observed in mice before bilateral vagotomy, without pretreatment with propranolol. These unexpected responses were observed in both WT (Fig. 6A) and M 1 -KO mice (Fig. 6B) . (Among the 12 WT mice tested, 11 mice showed atrioventricular block and three mice exhibited atrial fibrillation or flutter after injection of ACh; of the seven M 1 -KO mice tested with ACh, six displayed atrioventricular conduction block and three mice had atrial fibrillation or flutter). The threshold of the responses to ACh (10 -100 g/kg) was similar in WT and M 1 -KO mice.
Mice Lacking M 1 mAChR Demonstrate No Change in M 2 mAChR Expression in Heart. M 1 mAChR Is Not Detectable in Wild-Type Mouse Heart
Immunoprecipitation. Because of the data indicating the presence of M 1 mAChR in the heart of rats and other mammals, we tested whether the M 1 receptor could be detected in WT mouse heart and whether the expression of mAChR was altered in M 1 -KO mice. The total number of mAChR in atrial and ventricular tissues was determined using the nonselective muscarinic antagonist [ 3 H]QNB. In both tissues, there was not a statistically significant difference in mAChRs number among the three genotypes: WT, heterozygote (HET), and M 1 -KO (Fig. 7) . M 1 and M 2 mAChRs were immunoprecipitated from atria and ventricles of WT, HET, and M 1 -KO mice (Fig. 7) . Essentially all of the mAChR consisted of M 2 mAChRs (Fig. 7) . The density of M 2 mAChRs is unchanged in the atria and ventricle of the M 1 mutant mice. M 1 mAChR expression in WT atria and ventricles is near or at background levels and is not RT-PCR Experiments. RT-PCR was also used in an effort to detect low levels of M 1 mAChR mRNA in mouse heart. A representative result is shown in Fig. 8 . As expected, a strong signal was present in the cortex where M 1 mAChR constitutes 50% of the total mAChR (Hamilton et al., 1997) . No signal was detected in any tissue from the M 1 -KO mouse, or in the cardiac tissues in the WT mouse.
Using immunoprecipitation experiments, Hamilton et al. (1997) were unable to detect M 1 mAChR in mouse cerebellum. The ability of the more sensitive RT-PCR technique to detect M 1 mAChR mRNA in cerebellum but not heart indicates that the M 1 mAChR is most likely not expressed in either mouse atria and ventricles.
Carbachol-Stimulated PLC Activity Is the Same in WT and M 1 -KO Mice
Two mechanisms have been advanced to account for the stimulatory effects of muscarinic agonists on the heart: one involves an increase in intracellular Na ϩ concentration (by raising membrane permeability to Na ϩ ); the second mechanism involves stimulation of PLC, via Gq protein, which induces Ca 2ϩ release from the endoplasmic reticulum via the inositol triphosphate released after PLC activation (Nathanson, 1987) . M 1 mAChRs have been reported to mediate activation of PLC activity in guinea pig cardiomyocytes in culture (Gallo et al., 1993) . We measured mAChR agoniststimulated PLC activity in atrial and ventricular tissues from adult WT and M 1 -KO mice (Fig. 9) .
The cholinergic agonist carbachol (1 mM) induced an increase in PLC activity in both WT and M 1 -KO cardiac tissues. In ventricle, increases of 128 Ϯ 36 and 94 Ϯ 27% over basal were observed in WT and M 1 -KO, respectively (Fig.  9A) . Incubation of atria with carbachol resulted in increases of 53 Ϯ 12 and 43 Ϯ 11% from WT and M 1 -KO mice, respectively (Fig. 9B) . If there were M 1 mAChRs in cardiac tissue, a greater PLC activity would be expected in WT than M 1 -KO tissues; however, no significant difference in mAChR-mediated stimulation of PLC activity in hearts from WT and M 1 -KO mice was observed.
Discussion
The main goal of this study was to determine the effects of elimination of the M 1 mAChRs on the function of the heart in vivo. Although the M 2 receptor is the main muscarinic subtype present in the heart and is responsible for the inhibitory effects of ACh, there have been conflicting data on the poten- We first compared the basal hemodynamic variables to determine whether the lack of M 1 mAChR had any influence on cardiac function at rest. Both developed left ventricular pressure and LV dP/dt max as well as HR are similar between WT and M 1 -KO mice, showing that the loss of M 1 mAChR has no effect on basal cardiac function. We then determined the effects of administration of the muscarinic agonist McN-A-343 in WT and M 1 -KO mice. In WT mice, the agonist McN-A-343 was able to induce tachycardia, positive inotropism, and an increase in blood pressure. The increase in HR and MBP due to McN-A-343 administration observed in our study is in agreement with previous results reported on rat, dog, and cat (Roszkowski, 1961; Hammer and Giachetti, 1982; Wilffert et al., 1983) .
None of the mice treated with McN-A-343 either before or after bilateral vagotomy showed a transient decrease in mean blood pressure before the McN-A-343-mediated increase in blood pressure. This indicates that McN-A-343 did not cause peripheral vasodilation and that the positive inotropic and chronotropic cardiac effects were not a baroreceptor reflex response to hypotension. On the other hand, the effect of McN-A-343 on the force of contraction in WT mice Fig. 5 . Cardiac responses to intravenous nicotine in vagotomized WT and M 1 -KO mice. LV dP/dt max (A), DLVP (B), and heart rate (C). Both WT (n ϭ 8; f) and M 1 -KO mice (n ϭ 7; छ) were treated with increasing doses of nicotine (0.01-1 mg/kg). The results are expressed as the difference from basal values Ϯ S.E.M. WT and M 1 -KO mice do not differ in their responses to nicotine (p Ͼ 0.05; ANOVA). This indicates that the lack of a response to the M 1 receptor agonist McN-A-343 in WT mice was not due to an unresponsive preparation.
Fig. 6.Effect of ACh on atrioventricular conduction in WT (A)
and M 1 -KO (B) mice. Mice were pretreated with 1 mg/kg propranolol before injections of ACh to avoid sympathetic reflexes. Before injection of ACh, P waves are observable before the QRS complex. Immediately after injection of 100 g/kg i.v. ACh there are persistent P waves with irregular QRS complexes, indicating atrioventricular heart block. The atrial rate did not change after the injection of ACh, indicating the absence of a bradycardic effect on the sinoatrial node. The initial threshold effect of intravenous ACh is atrioventricular block without slowing of the atrial rate. Similar results were observed in mice that did not receive a propranolol pretreatment.
was blocked by the ␤-adrenergic receptor antagonist propranolol. These observations together indicate that McN-A-343 probably acts at the postganglionic sympathetic nerves, which is consistent with previous work reported in other species (Roszkowski, 1961; Martin, 1996) .
In pithed normotensive rats, the dose-dependent increase in blood pressure after the injection of McN-A-343 was strongly reduced in the presence of the M 1 /M 4 antagonist pirenzepine (Hammer and Giachetti, 1982; Wilffert et al., 1983) . It has also been previously shown that M 1 -mediated suppression of the M-current potassium channel is completely absent in sympathetic ganglia from M 1 -KO mice (Hamilton et al., 1997) . However M 1 , M 2 , and M 4 mAChR are all expressed in the sympathetic ganglia (Caulfield, 1993) . In the present study WT mice displayed a dose-dependent increase in both heart rate and LV dP/dt max when injected with McN-A-343, but the M 1 -KO mice did not. This clearly demonstrates that McN-A-343-induced responses are mediated by M 1 mAChR.
Although the apparent decreases in hemodynamic values observed at higher doses of McN-A-343 (500 -1500 g/kg) in M 1 -KO mice might be due to a nonselective stimulation of cardiac M 2 mAChR, these decreases were not statistically different from the basal values.
Activation of nicotinic receptors in sympathetic ganglia induces catecholamine release from the endings of postganglionic cells, which results in an increase in both force and rate of contraction by stimulating the cardiac ␤-adrenergic receptors. Administration of nicotine produced a similar response in both WT and M 1 -KO mice, demonstrating that the lack of response to McN-A-343 in the KO mice was not due to a generalized defect in sympathetic transmission to the heart or an artifact of the surgical procedures.
Pharmacological studies have suggested a functional role for the M 1 mAChR in adult guinea pig (Gallo et al., 1993) and rat cardiomyocytes (Sharma et al., 1996) . In rat cardiomyocytes, the stimulatory effects of mAChR agonists were significantly inhibited by antisense oligonucleotides directed against the M 1 mAChR subtype (Colecraft et al., 1998) . In addition, RT-PCR analyses detected the expression of M 1 mAChR in adult rat and guinea pig ventricular myocytes in culture (Gallo et al., 1993; Sharma et al., 1996) . 5 g) , and cerebellum, atria, and ventricles (1.5 g each) were tested for M 1 mAChR mRNA expression. Each RNA sample was reverse transcribed in the presence (ϩ) or absence (Ϫ) of reverse transcriptase (to test for genomic DNA contamination) before amplification by primers designed in the third cytoplasmic loop. The PCR products were analyzed on a 1.0% agarose gel, transferred to nylon membrane, and hybridized with the 1.8-kilobase fragment encoding the entire coding region of the M 1 mAChR. The M 1 mAChR mRNA is expressed in both cortex and cerebellum but is not detectable in mouse heart. 
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We performed biochemical and functional studies on mouse cardiac tissue to determine whether M 1 mAChRs were also expressed in the mouse heart. Immunoprecipitation analyses showed that the M 1 -KO mice had unaltered levels of expression of M 2 receptors in the heart. Our results also show no statistically significant expression of the M 1 mAChR expression in WT mouse heart. We also used RT-PCR to detect M 1 mAChR mRNA in total RNA from WT heart. Despite multiple experimental conditions to increase sensitivity (two sets of primers to get a double amplification, radioactive PCR, variations in RT-PCR conditions, several RNA concentrations), we were not able to detect any signal in cardiac tissue from WT mice. Because we were able to detect M 1 mAChR mRNA in the cerebellum from WT mice, where the expression of M 1 mAChR represents less than 5% of total mAChR in cerebellum (Caulfield, 1993) , the procedure was sensitive enough to detect very low levels of M 1 mAChR mRNA.
We also attempted to measure functional responsiveness of M 1 mAChRs in cardiac tissue. The mouse M 1 mAChR in transfected cells is preferentially coupled to the activation of PLC (Shapiro et al., 1988) . Furthermore, M 1 mAChR is the main mAChR subtype coupled to activation of the PLC pathway in mouse cerebral cortical neurons (Hamilton and Nathanson, 2001 ). We measured the muscarinic agonist-mediated stimulation of PLC activity in heart from WT and M 1 -KO mice. If M 1 mAChRs are present in cardiac WT tissue, PLC activity would be expected to be higher in WT tissue than in M 1 -KO tissue. However, there was no significant difference in carbachol-mediated stimulation of PLC between WT mice compared with M 1 -KO.
These biochemical results indicate that, in contrast to rat and guinea pig hearts, M 1 mAChRs are not expressed in the mouse heart. This is consistent with our physiological data showing that the effects of McN-A-343 are the consequence of activation of M 1 mAChR in the sympathetic ganglia (present study) and with the fact that McN-A-343 did not have any effect on the isolated mouse atria (Nishimaru et al., 2000) . Our results also are in agreement with the report of Roszkowski (1961) who observed, in dog, an McN-A-343-induced rise in blood pressure in vivo but did not report any effect on isolated heart from dog, rabbit, and cat, suggesting the absence of M 1 mAChR in this tissue (Roszkowski, 1961; Shi et al., 1999b) .
To determine whether the lack of M 1 mAChR in the KO mice affected the responsiveness of M 2 mAChR, ACh was injected in both WT and M 1 -KO mice and the responsive effects were recorded by ECG. Both WT and M 1 -KO mice responded to ACh with a similar threshold (data not shown), demonstrating that the lack of M 1 mAChR did not result in any change in M 2 mAChR-mediated response. However, the prominent effect of ACh on cardiovascular function in many mammals is to slow the rate of the sinus node depolarization. Unexpectedly the main and immediate effects of intravenous ACh on the mouse heart were the induction of atrioventricular conduction block, atrial flutter, or atrial fibrillation. Over a wide range of doses (0.01 pg/kg-200 g/kg) sinus bradycardia was only barely and inconsistently detected. Similar Gi-coupled receptor-mediated arrhythmias have been also described in transgenic and knockout mice (Redfern et al., 2000; Kovoor et al., 2001 ). Because we never detected sympathetic reflex-mediated stimulation of the heart in mice treated with ACh in the absence of propranolol (data not shown), it is unlikely that the absence of AChinduced bradycardia is the result of a sympathetic reflex that might have buffered the bradycardia. The absence of AChinduced bradycardia could result from the high level of acetylcholinesterase in the sinus node (Loffelholz and Lindmar, 1994) . This would prevent ACh from acting at the sinus node level, but would allow an action on the atrioventricular node where the concentration of acetylcholinesterase is lower (Loffelholz and Lindmar, 1994) . This hypothesis is supported by the results of Walker et al. (1999) and Feniuk and Large (1975) , who were able to detect bradycardia after injection of mice with the agonist methacholine (which is partially resistant to hydrolysis) or after injection of ACh into mice pretreated with the cholinesterase inhibitor physostigmine.
Because pharmacologically administered ACh did not appear to affect the sinoatrial node, the role of vagal tone in regulating murine heart rate was examined. WT and M 1 -KO mice both exhibit tachycardia in response to bilateral vagotomy, indicating that the vagus did mediate a tonic inhibition of the sinoatrial node in resting mice.
In summary, we have shown that 1) McN-A-343 induces both tachycardia and a positive inotropic effect, as well as an increase in blood pressure, in vivo in mice, due to M 1 mAChR activation of postganglionic sympathetic neurons innervating the heart; 2) M 1 mAChRs are not detected in the WT mouse heart tissue; 3) the lack of M 1 mAChR does not modify M 2 mAChR cardiac responsiveness in vivo; and 4) pharmacological administration of ACh in mouse rarely results in sinus bradycardia but usually results in atrioventricular block, atrial fibrillation, or atrial flutter as the initial threshold effect.
